OTC Mouthpiece for Snoring

Zyppah, Inc.604 enrolled

Overview

Online patient registration to participate in clinical trial to test OTC mouthpiece that controls position of the tongue to reduce snoring.

Patient will complete informed consent, inclusion/exclusion criteria, sleep apnea and snoring surveys online. If patient meets all criteria for the study, patient will be provided with a treatment device for use for a 10 day treatment period. Patient will complete the trial upon providing final online surveys.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

604

Conditions

Snoring

Interventions

Zyppah Anti-snoring ApplianceDEVICE

Use of an OTC mouth guard at night to prevent snoring

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Over 18 years of age * Living in the United States * Signing the Informed Consent Form Exclusion Criteria: * Missing teeth (as the device won't be properly fitted) * Any severe breathing or respiratory disorder, such as chronic asthma, emphysema, COPD, or a similar condition * Poor dental health, such as severe gum disease, loose teeth, an abscess, mouth sores, or bleeding gums * A dental implant placed within the last three months * Diagnosed with a Temporomandibular joint condition (TMJ) * Actively experiencing any mouth or jaw pain, including clenching of the teeth, grinding, or any other physical injury to the jaw or teeth * Full dentures * Braces * Diagnosis of sleep apnea * Less than 18 years of age

Locations (1)

The EyeDeas Company

Lake Forest, California, United States

Outcomes

Primary Outcomes

Snoring Severity Scale

The Snoring Severity Scale (SSS) is a 9-point, validated scale to measure the severity of snoring. A total of three questions are asked: 1) "How often do you snore, 2) "How long do you snore", and 3) How audible is your snoring. Answers for each of these questions are summed for a total SSS score. A score of '0' would indicate no snoring at all, while a score of '9' would indicate the most severe snoring as measured by the SSS. Outcome measure reported as change with use of the device over pre-trial. In this case, a negative ('-') would represent improvement in snoring symptoms, while a positive ('+') number would indicate an increase in snoring severity.

Time frame: Baseline and 10 Days

Visual-Analogue Scale, Self-Reported Snoring Habits

Quantitative assessment on 1-10 scale. Outcome measurement reported as a percentage change from pre-trial with use of the device. A negative ('-') percentage would indicate a reduction in snoring symptoms as measured by the VAS, while a positive percentage ('+') result would indicate an increase in the measured symptom.

Time frame: Baseline and 10 Days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.